logo
Share SHARE
FONT-SIZE Plus   Neg

Bluebird Bio Announces Closing Of IPO, Exercise Of Over-Allotment Option

bluebird bio, Inc., announced the closing of its initial public offering of 6.8 million shares of common stock at an initial public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 891,176 additional shares of common stock. All of the shares in the offering were offered by bluebird bio.

The company's common stock is listed on The NASDAQ Global Select Market under the trading symbol "BLUE."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
British lender Lloyds Banking Group Plc. Friday reported higher profit in its first half, benefited by increased net interest income and margin as well as lower impairment. Looking ahead, the company lifted its net interest margin forecast. Amgen reported an increase in second-quarter profit, driven by sales of arthritis drug Enbrel and osteoporosis treatments Xgeva and Prolia, and improved margins. Both earnings and sales topped Wall Street estimates. Electronic Arts Inc. (EA) on Thursday reported an increase in profit for the first quarter, reflecting continued strong digital revenues, with both earnings and revenues topping Wall Street estimates. However, shares of the company fell over 4 percent, after having detailed a weak outlook. Redwood...
comments powered by Disqus
RELATED NEWS
Trade BLUE now with 
Follow RTT